Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Herceptin“
Suchtreffer
Begriffe & Kennungen
Herceptin · 4.8 · Congestive heart failure (NYHA Class II – IV) is a common adverse reaction associated with the use of Hercepti
Eintrag öffnenHerceptin · 4.8 · Congestive heart failure (NYHA Class II-IV) is a common adverse reaction to Herceptin. It has been associated
Eintrag öffnenHerceptin · 4.8 · Description of selected adverse reactions
Eintrag öffnenHerceptin · 4.8 · Description of selected adverse reactions
Eintrag öffnenHerceptin · 4.8 · Description of selected adverse reactions with the subcutaneous formulation
Eintrag öffnenHerceptin · 4.8 · Details of risk minimisation measures that are consistent with the EU Risk Management Plan are presented in (s
Eintrag öffnenHerceptin · 4.8 · Details of risk minimisation measures that are consistent with the EU Risk Management Plan are presented in Se
Eintrag öffnenHerceptin · 4.8 · Febrile neutropenia, leukopenia, anaemia, thrombocytopenia and neutropenia occurred very commonly. The frequen
Eintrag öffnenHerceptin · 4.8 · Febrile neutropenia, leukopenia, anaemia, thrombocytopenia and neutropenia occurred very commonly. The frequen
Eintrag öffnenHerceptin · 4.8 · Haematotoxicity
Eintrag öffnenHerceptin · 4.8 · Haematotoxicity
Eintrag öffnenHerceptin · 4.8 · Hypertensive events
Eintrag öffnenHerceptin · 4.8 · Immunogenicity
Eintrag öffnenHerceptin · 4.8 · Immunogenicity
Eintrag öffnenHerceptin · 4.8 · In 3 pivotal EBC clinical trials of adjuvant intravenous Herceptin given in combination with chemotherapy, the
Eintrag öffnenHerceptin · 4.8 · In 3 pivotal clinical trials of adjuvant Herceptin given in combination with chemotherapy, the incidence of gr
Eintrag öffnenHerceptin · 4.8 · In the neoadjuvant-adjuvant EBC study (BO22227), at a median follow-up exceeding 70 months, 10.1 % (30/296) of
Eintrag öffnenHerceptin · 4.8 · In the neoadjuvant-adjuvant EBC study (BO22227), at a median follow-up exceeding 70 months, 10.1% (30/296) of
Eintrag öffnenHerceptin · 4.8 · In the pivotal metastatic trials of intravenous Herceptin, the incidence of cardiac dysfunction varied between
Eintrag öffnenHerceptin · 4.8 · In the pivotal metastatic trials of intravenous Herceptin, the incidence of cardiac dysfunction varied between
Eintrag öffnen